Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior.
Giovanna RevillaNuseibah Al QtaishPablo CaruanaMyriam Sainz-RamosTania Lopez-MendezFrancisco RodriguezEnma V Páez EspinosaChangda LiNúria Fucui VallverdúMaria EdwardsAntonio MoralJosé Ignacio PérezJoan Carles Escolà-GilJosé Luis PedrazIdoia GallegoRosa CorcoyMaría Virtudes CéspedesGustavo PurasEugènia MatoPublished in: Biomolecules (2023)
These proof-of-concept findings suggest a promising strategy for administering TKIs in a more targeted and effective manner.